[Federal Register Volume 70, Number 128 (Wednesday, July 6, 2005)]
[Notices]
[Pages 38984-38985]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-13232]


-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[File No. 1-07598]


Issuer Delisting; Notice of Application of Varian Medical 
Systems, Inc. To Withdraw its Common Stock, $1.00 Par Value, and 
Associated Preferred Stock Purchase Rights, From Listing and 
Registration on the Pacific Exchange, Inc.

June 29, 2005.
    On June 14,2005, Varian Medical Systems, Inc., a Delaware 
corporation (``Issuer''), filed an application with the Securities and 
Exchange Commission (``Commission''), pursuant to Section 12(d) of the 
Securities Exchange Act of 1934 (``Act'') \1\ and Rule 12d2-2(d) 
thereunder,\2\ to withdraw its common

[[Page 38985]]

stock, $1.00 par value, and associated preferred stock purchase rights 
(``Securities''), from listing and registration on the Pacific 
Exchange, Inc. (``PCX'').
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78l(d).
    \2\ 17 CFR 240.12d2-2(d).
---------------------------------------------------------------------------

    On May 19, 2005, the Board of Directors (``Board'') of the Issuer 
approved resolutions to withdraw the Securities from listing and 
registration on PCX. The Issuer stated in its application that the 
Securities are listed on both the New York Stock Exchange, Inc. 
(``NYSE'') and PCX. The Issuer stated that the Board's reason for 
requesting withdrawal of the Securities is the belief by the Board and 
Issuer that the benefits of being listed on PCX's are outweighed by the 
added administrative burdens and expenses.
     The Issuer stated in its application that it has complied with PCX 
rules by complying with all applicable laws in effect in the state of 
Delaware, the state in which the Issuer is incorporated, and by filing 
with PCX the required documents governing the withdrawal of securities 
from listing and registration on PCX.
    The Issuer's application relates solely to the withdrawal of the 
Securities from listing on PCX and shall not affects continued listing 
on the NYSE or its obligation to be registered under Section 12(b) of 
the Act.\3\
---------------------------------------------------------------------------

    \3\ 15 D.S.C. 781(b).
---------------------------------------------------------------------------

    Any interested person may, on or before July 25,2005, comment on 
the facts bearing upon whether the application has been made in 
accordance with the rules of PCX, and what terms, if any, should be 
imposed by the Commission for the protection of investors. All comment 
letters may be submitted by either of the following methods:

Electronic Comments

     Use the Commission's Internet comment form (http://www.sec.gov/rules/delist.shtml); or
     Send an e-mail to [email protected]. Please include 
the File Number 1-07598 or;

Paper Comments

     Send paper comments in triplicate to Jonathan G. Katz, 
Secretary, Securities and Exchange Commission, 100 F Street NE., 
Washington, DC 20549-9303.

All submissions should refer to File Number 1-07598. This file number 
should be included on the subject line if e-mail is used. To help us 
process and review your comments more efficiently, please use only one 
method. The Commission will post all comments on the Commission's 
Internet Web site (http://www.sec.gov/rules/delist.shtml). Comments are 
also available for public inspection and copying in the Commission's 
Public Reference Room. All comments received will be posted without 
change; we do not edit personal identifying information from 
submissions. You should submit only information that you wish to make 
available publicly.
    The Commission, based on the information submitted to it, will 
issue an order granting the application after the date mentioned above, 
unless the Commission determines to order a hearing on the matter.

    For the Commission, by the Division of Market Regulation, 
pursuant to delegated authority.\4\
---------------------------------------------------------------------------

    \4\ 17 CFR 200.30-3(a)(1).
---------------------------------------------------------------------------

Jonathan G. Katz,
Secretary.
[FR Doc. 05-13232 Filed 7-5-05; 8:45 am]
BILLING CODE 8010-01-M